[HTML][HTML] Cardiovascular adverse events in modern myeloma therapy–incidence and risks. A review from the European Myeloma Network (EMN) and Italian Society of …
Cardiovascular disease in patients with multiple myeloma may derive from factors unrelated
to the disease (age, diabetes, dyslipidemia, obesity, prior cardiovascular diseases), related …
to the disease (age, diabetes, dyslipidemia, obesity, prior cardiovascular diseases), related …
Cardiovascular adverse events in modern myeloma therapy-Incidence and risks. A review from the European Myeloma Network (EMN) and Italian Society of Arterial …
S Bringhen, A Milan, C Ferri, R Wäsch… - …, 2018 - pubmed.ncbi.nlm.nih.gov
Cardiovascular disease in patients with multiple myeloma may derive from factors unrelated
to the disease (age, diabetes, dyslipidemia, obesity, prior cardiovascular diseases), related …
to the disease (age, diabetes, dyslipidemia, obesity, prior cardiovascular diseases), related …
[PDF][PDF] Cardiovascular adverse events in modern myeloma therapy-Incidence and risks. A review from the European Myeloma Network (EMN) and Italian Society of …
S Bringhen, A Milan, C Ferri, R Wäsch, F Gay… - …, 2018 - iris.unito.it
Cardiovascular disease in patients with multiple myeloma may derive from factors unrelated
to the disease (age, diabetes, dyslipidemia, obesity, prior cardiovascular diseases), related …
to the disease (age, diabetes, dyslipidemia, obesity, prior cardiovascular diseases), related …
[HTML][HTML] Cardiovascular adverse events in modern myeloma therapy–Incidence and risks. A review from the European Myeloma Network (EMN) and Italian Society of …
S Bringhen, A Milan, C Ferri, R Wäsch, F Gay… - …, 2018 - haematologica.org
Cardiovascular disease in patients with multiple myeloma may derive from factors unrelated
to the disease (age, diabetes, dyslipidemia, obesity, prior cardiovascular diseases), related …
to the disease (age, diabetes, dyslipidemia, obesity, prior cardiovascular diseases), related …
Cardiovascular adverse events in modern myeloma therapy-Incidence and risks. A review from the European Myeloma Network (EMN) and Italian Society of Arterial …
S Bringhen, A Milan, C Ferri, R Wäsch, F Gay… - …, 2018 - europepmc.org
Cardiovascular disease in patients with multiple myeloma may derive from factors unrelated
to the disease (age, diabetes, dyslipidemia, obesity, prior cardiovascular diseases), related …
to the disease (age, diabetes, dyslipidemia, obesity, prior cardiovascular diseases), related …
Cardiovascular adverse events in modern myeloma therapy-Incidence and risks. A review from the European Myeloma Network (EMN) and Italian Society of Arterial …
S Bringhen, A Milan, C Ferri, R Wäsch, F Gay… - …, 2018 - cris.unibo.it
Cardiovascular disease in patients with multiple myeloma may derive from factors unrelated
to the disease (age, diabetes, dyslipidemia, obesity, prior cardiovascular diseases), related …
to the disease (age, diabetes, dyslipidemia, obesity, prior cardiovascular diseases), related …
[引用][C] Cardiovascular adverse events in modern myeloma therapy–Incidence and risks. A review from the European Myeloma Network (EMN) and Italian Society of …
S Bringhen, A Milan, C Ferri, R Wäsch, F Gay… - Haematologica, 2018 - cir.nii.ac.jp
Cardiovascular adverse events in modern myeloma therapy – Incidence and risks. A review
from the European Myeloma Network (EMN) and Italian Society of Arterial Hypertension (SIIA) …
from the European Myeloma Network (EMN) and Italian Society of Arterial Hypertension (SIIA) …
[PDF][PDF] Cardiovascular adverse events in modern myeloma therapy–Incidence and risks. A review from the European Myeloma Network (EMN) and Italian Society of …
haematologica, 2018 - core.ac.uk
Cardiovascular disease in patients with multiple myeloma may derive from factors unrelated
to the disease (age, diabetes, dyslipidemia, obesity, prior cardiovascular diseases), related …
to the disease (age, diabetes, dyslipidemia, obesity, prior cardiovascular diseases), related …
Cardiovascular adverse events in modern myeloma therapy-Incidence and risks. A review from the European Myeloma Network (EMN) and Italian Society of Arterial …
S Bringhen, A Milan, C Ferri, R Wäsch… - …, 2018 - pubmed.ncbi.nlm.nih.gov
Cardiovascular disease in patients with multiple myeloma may derive from factors unrelated
to the disease (age, diabetes, dyslipidemia, obesity, prior cardiovascular diseases), related …
to the disease (age, diabetes, dyslipidemia, obesity, prior cardiovascular diseases), related …
Cardiovascular adverse events in modern myeloma therapy-Incidence and risks. A review from the European Myeloma Network (EMN) and Italian Society of Arterial …
S Bringhen, A Milan, C Ferri, R Wäsch, F Gay… - …, 2018 - europepmc.org
Cardiovascular disease in patients with multiple myeloma may derive from factors unrelated
to the disease (age, diabetes, dyslipidemia, obesity, prior cardiovascular diseases), related …
to the disease (age, diabetes, dyslipidemia, obesity, prior cardiovascular diseases), related …